Ellen Moseholm1,2, Inka Aho3, Åsa Mellgren4,5, Isik S Johansen6, Merete Storgaard7, Gitte Pedersen8, Ditte Scofield1, Terese L Katzenstein9, Nina Weis1,10. 1. Department of Infectious Diseases, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark. 2. Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. 3. Department of Infectious Diseases, Helsinki University Hospital, Helsinki, Finland. 4. Department of Infectious Diseases, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden. 5. Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. 6. Department of Infectious Diseases, Odense University Hospital, Odense, Denmark. 7. Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark. 8. Department of Infectious Diseases, Aalborg University Hospital, Aalborg, Denmark. 9. Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. 10. Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Abstract
OBJECTIVE: The success of antiretroviral therapy has resulted in the normalization of pregnancy among women living with HIV and a very low risk of perinatal transmission of HIV. Despite these advances, women living with HIV still face complex medical and psychosocial issues during pregnancy. The purpose of this study is to describe experiences of pregnancy and the relevance of social support among women living with HIV in Nordic countries. METHODS: This qualitative study examined data from pregnant women living with HIV from sites in Denmark, Sweden and Finland from 2019 to 2020. Data were collected in the third trimester via individual interviews using a hybrid, narrative/semistructured format. The transcribed interviews were analyzed using narrative thematic analysis. RESULTS: In total, 31 women living with HIV were enrolled, of whom 61% originated from an African country and 29% from a Nordic country. The analysis generated four primary narrative themes: just a normal pregnancy, unique considerations and concerns, interactions with healthcare, and social support. Women living with HIV have a strong desire to have normal pregnancies and to be treated like any other pregnant woman. However, this normality is fragile, and being pregnant and living with HIV does come with unique considerations and concerns, such as fear of transmission, antiretroviral therapy, and the need for specialized care, which are fundamental to the women's experiences. Interactions with healthcare providers and social support influence their experiences in both positive and negative ways. CONCLUSION: The findings emphasize a sense of normality in pregnancy among women living with HIV. However, pregnancy does come with unique considerations and concerns, which highly influence the women's experience of pregnancy. Healthcare providers should focus on person-centered care, ensuring continuity and that women living with HIV do not feel discriminated against throughout their pregnancy.
OBJECTIVE: The success of antiretroviral therapy has resulted in the normalization of pregnancy among women living with HIV and a very low risk of perinatal transmission of HIV. Despite these advances, women living with HIV still face complex medical and psychosocial issues during pregnancy. The purpose of this study is to describe experiences of pregnancy and the relevance of social support among women living with HIV in Nordic countries. METHODS: This qualitative study examined data from pregnant women living with HIV from sites in Denmark, Sweden and Finland from 2019 to 2020. Data were collected in the third trimester via individual interviews using a hybrid, narrative/semistructured format. The transcribed interviews were analyzed using narrative thematic analysis. RESULTS: In total, 31 women living with HIV were enrolled, of whom 61% originated from an African country and 29% from a Nordic country. The analysis generated four primary narrative themes: just a normal pregnancy, unique considerations and concerns, interactions with healthcare, and social support. Women living with HIV have a strong desire to have normal pregnancies and to be treated like any other pregnant woman. However, this normality is fragile, and being pregnant and living with HIV does come with unique considerations and concerns, such as fear of transmission, antiretroviral therapy, and the need for specialized care, which are fundamental to the women's experiences. Interactions with healthcare providers and social support influence their experiences in both positive and negative ways. CONCLUSION: The findings emphasize a sense of normality in pregnancy among women living with HIV. However, pregnancy does come with unique considerations and concerns, which highly influence the women's experience of pregnancy. Healthcare providers should focus on person-centered care, ensuring continuity and that women living with HIV do not feel discriminated against throughout their pregnancy.
Entities:
Keywords:
experience; pregnancy; qualitative; women living with HIV
Globally, women account for more than half (54%) of all adults living with HIV, with
an estimated 19.3 million women living with HIV > 15 years of age in 2020. As a
result of increased coverage and improved regimens, 85% of the estimated 1.3 million
pregnant women living with HIV received antiretroviral therapy (ART) to prevent the
transmission of HIV to their children.
The use of combination ART (cART) has normalized pregnancy, including the
recommendation of vaginal delivery in well-treated women living with HIV. These
interventions have led to a dramatic decrease in perinatal transmission
worldwide.[1-4]Women living with HIV have fertility desires similar to those of the general
population.[5,6]
Motherhood is often experienced as something positive,
and pregnancy is usually connected to a sense of normality and the experience
of feeling whole.However, despite the normalization of pregnancy, becoming and being a mother with HIV
is associated with unique pregnancy and postpartum considerations.[9,10] In addition to the usual
adjustments to motherhood, pregnant women living with HIV must also cope with
stressors that include their health, the unknown infectious status of their infants,
and attending to their infants’ unique needs, such as the administration of
prophylactic medications.
Moreover, being pregnant may intensify concerns related to HIV disclosure,
HIV stigma, and worrying about the negative impacts of maternal HIV on children.The broader social and environmental context may be important determinants for the
experiences of pregnancy and the psychosocial well-being of women living with HIV.
Findings from a recent Swedish qualitative study highlight that feeling safe with
oneself and in one’s relationships with others is essential to women living with HIV.
This includes the presence of supportive relationships, including those with
healthcare providers.
How women living with HIV interact with healthcare providers may have a large
impact on their pregnancy experience.The annual number of HIV pregnancies has increased, both in Nordic countries and
internationally.[13-16] However, there is a gap in
the literature on the experiences of pregnancy among women living with HIV in
today’s context. Psychosocial and emotional well-being is essential during pregnancy
to facilitate attachment to one’s newborn and to develop the capacity to parent effectively.
Thus, understanding and responding to the experiences of pregnant and
postpartum women living with HIV are important so that goal-oriented interventions
supporting these women can be developed. The purpose of this study is to describe
the experiences of pregnancy and the relevance of social support among women living
with HIV in the Nordic countries of Denmark, Finland, and Sweden.
Methods
Study design
This is a qualitative interview study conducted within the 2BMOM study, a
multi-centre longitudinal mixed-methods study investigating psychosocial
outcomes and experiences of women living with HIV in Nordic countries during
pregnancy and early motherhood. Both quantitative and qualitative data were
collected to enhance understanding not only of the psychosocial health of women
living with HIV during pregnancy and postpartum but also to elucidate the
nuances and details of their’s experiences. Pregnant women living with HIV,
non-pregnant women living with HIV, and pregnant women without HIV were
recruited from seven sites in Denmark, Finland, and Sweden between January 2019
and December 2020. Quantitative data were collected via self-administered
electronic questionnaires, with a subsample of pregnant women living with HIV
taking part in semistructured qualitative interviews in the third trimester of
pregnancy and 6 months post-partum (n = 31). Methods are described in detail elsewhere.
Setting
There are approximately 1600, 1000 and 2800 women living with HIV in Denmark,
Finland, and Sweden.[16,19,20] The majority of women living with HIV in these
countries are immigrants, primarily from sub-Saharan Africa, and mostly became
infected with HIV through sexual contact.[13,16] The healthcare system in
Nordic countries is tax-based and ensures universal access to both medical
healthcare and many social support services.
Hence, cART is provided free of charge, and people living with HIV in
Nordic countries are generally well treated, with life expectancies approaching
those of the general population.[16,20,23] Most pregnant women
living with HIV have an undetectable viral load at the time of delivery,
resulting in a perinatal transmission rate of <1%.[4,16,21,24]
Ethics
All women gave voluntary, written informed consent to participate in the 2BMOM
study, which included both the quantitative and qualitative phases of the study.
All women were informed that they could withdraw their consent at any time,
without giving a reason and without it affecting current or future medical
treatment. The study was approved by the Danish Data Protection Agency
(VD-2018-253) and the Finnish and Swedish Ethics Committees (HUS/1330/2019 and
Dnr: 2019-04451, respectively). Approval from the Danish National Ethics
Committee was not required, as no biomedical intervention was performed.
Participants
All women living with HIV enrolled in the 2BMOM survey study were asked to
participate in a concurrent qualitative interview study. Hence, the
participating women were recruited for both the survey and interviews within the
same period from the participating sites (the Departments of Infectious Diseases
at Copenhagen University Hospitals, Hvidovre and Rigshospitalet, Odense,
Aalborg, and Aarhus University Hospitals in Denmark; the Department of
Infectious Diseases, Helsinki University Hospital, Finland; and the Department
of Infectious Diseases, Sahlgrenska University Hospital, Sweden) by medical
staff during routine clinical appointments. Pregnant women living with HIV were
asked to participate if they were 18 years or older, pregnant, expecting a
viable infant without life-threatening conditions or congenital anomalies, and
could speak and read Danish or English. The participants were consecutively
sampled until reaching data saturation (i.e. the point when no substantially new
information emerged from the interviews).[25,26] In total, 31 pregnant
women living with HIV agreed to participate in the interview study: 24 women
from Denmark, five women from Finland, and two women from Sweden. A summary of
their characteristics is presented in Table 1.
Table 1.
Characteristics of participating women (n = 31).
Age, years
Median (IQR)
33.9 (29.5: 36.6)
Range
23–45
Relationship status, n (%)
Married/living with a partner
25 (80)
Have a partner, but not living together
3 (10)
Do not have a current partner
3 (10)
Country of birth, n (%)
Nordic country (Denmark, Finland or Sweden)
9 (29)
Africa
19 (61)
Other
3 (10)
Education, n (%)
Primary/secondary school
11 (35)
Higher education (college/university)
20 (65)
Employment, n (%)
Yes, part or full time
18 (60)
Comorbidities*, n (%)
5 (16)
Nulliparous, n (%)
14 (45)
Years since HIV diagnosis, median [IQR]
8 [1 – 19]
HIV diagnosis during pregnancy, n (%)
Yes
3 (10)
Mode of HIV transmission, n (%)
Sexual
27 (87)
Perinatal transmission
4 (13)
ART treatment**, n (%)
NRTIs + NNRTI
7 (23)
NRTIs + PI
12 (39)
NRTIs + InSTI
11 (35)
Other
< 3 (3)
CD4 count**, n (%)
>500 cells/mL
21 (68)
⩽500 cells/mL
10 (32)
HIV viral load**, n (%)
<50 copies/mL
24 (77)
⩾50 copies/mL
7 (23)
Diabetes, psychiatric illness, asthma and anaemia.
At enrolment.
Characteristics of participating women (n = 31).Diabetes, psychiatric illness, asthma and anaemia.At enrolment.
Data collection
The data were collected through individual interviews between January 2019 and
December 2020 among women in the third trimester of pregnancy. All interviews
were conducted by the first author (EM) using a hybrid, narrative/semistructured
format.[27,28] The opening question was: ‘Can you tell us what your
pregnancy experiences have been like for you as a woman living with HIV?’ This
allowed each woman to share her story. Probes were used as clarifying and
elaborating questions throughout the interviews, thus expanding the stories the
women shared within the larger narrative.
Hence, the participants were initially asked to give a full narrative of
their experiences. This was followed by a series of semistructured questions and
probes to elaborate on themes not brought up by the interviewees (see the
Interview guide in Supplemental material 1). The interviews were conducted in
Danish or English and in the participant’s home, at the relevant hospital, or
online using a video meeting setup, whichever setting the woman preferred. The
interviews lasted between 20 and 90 minutes (mean: 51 minutes), were
audio-recorded, and were transcribed verbatim.
Analysis
The transcribed interviews were examined using narrative thematic analysis as
described by Riessman.[29,30] An inductive approach was used with an emphasis on the
content of the text: ‘what’ is said more than ‘how’ it is said.
Hence, the data were analyzed textually. The analysis involved several
steps. First, an initial coding focusing on capturing the main ideas from the
women’s stories was conducted. Emergent themes and patterns across a subset of
transcripts were identified and discussed among the team members (EM, NW, and
DS) while paying close attention to the uniqueness of the entire story that was
told and the study’s aims. The themes were then compared for similarities and
differences across participants and their narratives (EM, NW, and DS). Next, the
themes were brought together to create and define the primary narrative themes,
and a codebook was developed to document and organize the codes (EM and
DS). In the final step, the codebook was used to code and explore all interview
data using NVivo software, QSR International Pty Ltd, to support data management
(EM). Special attention was given to any new themes or perspectives emerging
during this phase of analysis. The initial investigation was conducted by EM,
NW, and DS. EM and DS worked together in the subsequent analysis to critically
reflect on and review interpretations of the findings, and to ensure that the
findings were based on the participating women’s narratives.
Trustworthiness
Several procedures were employed to enhance trustworthiness and credibility
throughout the study (see Supplemental material 2 for a completed COREQ checklist). First,
several authors were involved in the analysis, documenting every step of the
analytical procedures and holding consensus meetings to establish agreement on
thematic categories.[31,32] Second, a detailed description of the context and
research process is provided to enhance the transparency of the results.
Finally, the identified themes are described in detail, including quotes from
the women to show confirmability between the data and findings.
In cases where the original quotes were in Danish, they were translated
by bilingual researchers using the forward–backward translation method.
Results
The analysis generated four primary narrative themes, highlighting the ways that
women living with HIV narrate their pregnancy experiences: (1) just a normal
pregnancy; (2) unique considerations and concerns; (3) interactions with
healthcare and (4) social support (Figure 1). These four themes are
connected throughout the narratives and to the women’s history and previous
experiences.
Figure 1.
Coding tree.
Coding tree.
Just a normal pregnancy
Emerging from the women’s narratives were multiple stories about the concept
of normality.The feeling of normality was related to both pregnancy and
delivery: being pregnant brought a sense of normality to the
women, which increased acceptance of being able to live a good life with HIV:‘I’m like a normal person even with the infection. In addition, that
was like, that’s cool . . . and happy sometimes that . . . I can be
normal . . . [laughing] . . . Without being . . . totally healthy,
like I can be a mother, and sometimes I have my infection and accept
it the way it is, and my baby will be fine. To think about that is a
very big relief for me.’ (ID 22, age 20–24, immigrant)Having a normal pregnancy was important to many of the women; they did not
want to be treated differently than other pregnant women. The participants
knew about the precautions needed throughout the pregnancy but felt that as
long as they were compliant with their medicine, the focus should be on the
pregnancy and less on their HIV. ‘I take my medicine every day, right? So I
am just as normal as people not living with HIV’ (ID 9, age 25–30, born in a
Nordic country).Planning for and having a vaginal delivery was important, as this increased
the feeling of normality. However, some women had doubts about the risks and
lack of control associated with a vaginal delivery:‘And that is why I am asking now, what kind of birth should I be
doing . . . a natural birth or caesarean? The caesarean, they can
control it more. The professionals. The natural birth can go wrong,
that they can’t control . . . maybe they can’t control.’ (ID 28, age
35–40, immigrant)For many participants, being in control was important, and
pregnancy changed this in several ways. Pregnancy was associated with social
expectations, and the women often had to explain why they were having extra
scans or planning to deliver at a specific hospital. This was especially
prevalent among women who had not disclosed their HIV status:‘Sometimes it is hard to explain at work or with relatives because I,
I have to, the scans are made by doctors at the hospitals, while
normally it would be done by midwives at the local health care
centre so it’s always with this HIV you have to have this
explanation ready.’ (ID 29, age 30–35, born in a Nordic country)Being a mother already brought a different perspective because the women knew
what to expect both with pregnancy and their HIV, which made them experience
less anxiety:‘I think it is because I have my daughter. I am not concerned because
I have done it before, so to speak.’ (ID 3, age 35–40, born in a
Nordic country)The feeling of normality was fragile and often interrupted
by encounters of medical surveillance or complications. For example, if the
women experienced complications or concerns during their pregnancy, they
often found it difficult to distinguish if this could be due to their
pregnancy, HIV, or medication. ‘I am pregnant and I’m taking the medicine,
so is it the side effects from the medicine or the pregnancy?’ (ID 16, age
30–35, immigrant). Narratives from women who were pregnant during the
COVID-19 pandemic revealed that for some this was associated with increased
anxiety concerning both pregnancy and HIV infection. ‘I should be careful of
Corona, I should be careful of HIV [short laugh], I should be careful of
everything’ (ID 23, age 35–40, immigrant).For the women who were diagnosed with HIV during pregnancy, the focus was
less on normality and more on coping and managing both their HIV diagnosis
and pregnancy. They described feelings of ambivalence, as they were happy
about the pregnancy, but also concerned and confused about their HIV
diagnosis and what it meant for their baby:‘I was happy and sad about this pregnancy. You know, to be pregnant,
and you don’t know you are pregnant, and you have this virus, and
you don’t know that you are HIV-positive. I mean, I can’t bear it.’
(ID 27, age 37, immigrant)
Unique considerations and concerns
Being pregnant and living with HIV comes with unique considerations and
concerns, which very much affected how the women experienced their
pregnancies. Many participants changed their antiretroviral
therapy regimens either because they were planning to become
pregnant, or early in pregnancy due to the risk of teratogenicity. This
often resulted in having to take more tablets and increased side effects.
Nausea was common among the participants, and the women found it difficult
to determine whether it was caused by pregnancy, antiretroviral medicine, or
a combination of both:‘I think it is double up. I think they enhance each other because I
can take the medicine and be nauseous, but not throw up. I am just
nauseous. But add the pregnancy, and there can be some very
interesting nights and mornings.’ (ID 3, age 35–40, born in a Nordic
country)Although many of the women were very grateful for their antiretroviral
therapy, taking the pills every day was also a reminder of their HIV.
However, being pregnant enhanced the significance of taking the medicine,
and the women were highly aware that this was important not only for their
health but also for the health of their babies.Thoughts about infant prophylactic therapy provided after
delivery were also prevalent during pregnancy. Some women just accepted it,
thinking the medicine helped protect their babies, while others were
concerned and felt guilty about it:‘I feel bad for her. It is not her fault, and yet she still has to
suffer in a way, right? I’m thinking that if I’m feeling this bad,
then how will a baby react to the medicine? I don’t know, but I just
think it is bad for her, giving her the medicine . . . I know she
must have it, but I just feel guilty, that she needs to have it when
it is not her fault.’ (ID 13, age 20–25, born in a Nordic
country)Throughout their pregnancies, most of the women worried about
transmitting HIV to their children, despite being well
informed about the low risk of perinatal transmission. The women, who were
already mothers, found reassurance in the fact that they had had children
before who were healthy and not infected. Many of the women knew the science
and were aware that this fear of transmission was not rational, but it was
still a very real concern during pregnancy:‘I know the risk is minimal, but all this talk about HIV not being
transmittable and all that, has meant that it is not something I
think about for myself. But now it is something else, with my child,
because I fear that she might get it.’ (ID 9, age 25–30, born in a
Nordic country)Many women felt reassured after they talked to healthcare providers. However,
some women felt that perhaps the risk of transmission was downplayed and
expressed doubts about whether they could trust healthcare providers:‘Being pregnant and sitting across from all these doctors, nurses,
and therapists saying you don’t need to worry about that. We would
rather have HIV than diabetes, I mean come on. I just reached a
point where I became irritated, thinking that there may be something
negative, some risk still exists; tell me about it.’ (ID 8, age
40–45, born in a Nordic country)
Interactions with healthcare
Women’s close contact with the healthcare system and their interactions with
healthcare providers were essential to their pregnancy experience. This was
associated with their previous experiences, their expectations, and their
cultural background. The narratives revealed that the participants’
experiences with healthcare providers were mostly positive. The women also
expressed great appreciation for the care providers and
were very grateful to live in a country with a good healthcare system. This
was especially prevalent among the women originating from Africa, who
compared the care they were receiving to the healthcare systems in their
home country:‘My worry was that if I was in Africa, maybe I would have been dead
by now. Because maybe the medicine you have to buy, you don’t have a
good job, you don’t eat good food and you worry all the time. So I
am happy to be here.’ (ID 4, age 25–30, immigrant)The women received tailored care throughout the pregnancy,
which included extra clinical appointments and scans; for some women, this
was reassuring. They often saw the same providers, who specialized in HIV,
at each clinical appointment, and this was a positive experience that made
them feel normal, encouraged, and supported:‘They take the time to talk and listen, to understand, and to use the
extra time. You know, like they truly care. I am happy about that.
In addition, I don’t feel abnormal when I see the doctor. They make
sure of that. If I feel different than others, they tell me I am
not, and it is important that I know that.’ (ID 16, age 30–35,
immigrant)However, the narratives also highlighted that for some women, the need for
specialized care was a burden, making them feel different from other
pregnant women:‘It has been too much. I have talked to other pregnant ladies, and
they have not had half the scans that I have. In addition, I cannot
understand that just because you have the illness I have, that the
baby shouldn’t grow normally. In addition, that is why I need to go,
so they can check if the baby is growing normally.’ (ID 3, age
35–40, born in a Nordic country)Some women also felt that the extra check-ups and tests were associated with
increased anxiety because the chance of finding something that needed
additional monitoring increased:‘It sometimes feels like full-time work to be pregnant and keeping
track of all the appointments . . . I am just thinking that
sometimes because there is an extra focus on you, you are put
through things that might not be necessary . . . because as an
expecting mother, I think your feelings are slightly sensitive, and
mentioning alarming words has a big effect. I think this could be
avoided in many situations.’ (ID 30, age 30–35, born in a Nordic
country)Some of the women had other complications such as bleeding, abnormal growth,
or the risk of pre-eclampsia, which needed closer follow-ups; this was often
more easily accepted, as the need for close monitoring was not associated
with their HIV. The many clinical appointments during pregnancy could be
challenging to manage along with work and other commitments. However, the
providers tried to align appointments on the same day to minimize the number
of hospital visits; this was much appreciated by the women.In nonspecialist departments, some providers seemed to lack
knowledge of HIV. This was related to both past experiences and experiences
during pregnancy, which created feelings of mistrust and insecurity. The
women felt they were put in situations where they had to update the
healthcare providers on HIV or to answer questions about their HIV that were
not relevant to the situation. These experiences added an extra layer of
anxiety and a fear of stigma linked to the delivery:‘My biggest fear of giving birth is to have a midwife that is afraid
of me. When you are going to deliver a baby, it is one of the
biggest things in your . . . in a person’s life. Everybody deserves
to feel like . . . they should not have to deal with other people’s
fear on that specific day.’ (ID 31, age 30–35, born in a Nordic
country)
Social support
Support from others, or lack thereof, had a large influence on the women’s
experiences throughout pregnancy. Support from family and
friends was experienced as both positive and challenging. Many of
the participants were immigrants originating from Africa. They often had poor
support networks, and some had an unresolved immigration status. This affected
their pregnancy experience in many ways, including increased anxiety, isolation,
and feelings of loneliness:‘No, I am alone here. I am alone here. That is why I don’t have any
connections, truly. Even my husband’s family they are . . . they are his
family. In addition, it is a different culture than ours.’ (ID 14 age
40–45, immigrant)Many of the women had close contact with their family living in their home
country, and several of the women were planning to have family members visiting
closer to the birth. This was often a great source of support but also brought
about much anxiety if they had not disclosed their HIV status. These women had
many thoughts about how to hide their own medicine, the baby’s medicine, and the
fact that they were not breastfeeding:‘My mom is coming here . . . she doesn’t know anything about my
infection. So I have to make a special effort to keep it secret because
she will be living with us.’ (ID 28, age 40–45, immigrant)Women originating from Nordic countries expressed having more social support and
were also more likely to be open about their HIV status, which meant they were
more relaxed in their relationships with others. A few of the participants had
close friends who were also pregnant or new mothers, while others had friends
living with HIV while being parents, which was a great source of support for them:‘I have some friends who are HIV-infected and have kids. I think,
especially one friend, we support each other a lot because our lives are
very similar in many ways. We are the same age, well-treated, and so
on.’ (ID 3, age 35–40, born in a Nordic country)The women who were perinatally infected with HIV often found support within their
own families, especially their mothers, because they felt their mothers could
relate to some of the unique concerns and worries related to both HIV and pregnancy:‘With my mother it is slightly more . . . also with the infection. She
understands slightly more about how I feel. I truly rely on her. She is
a great source of support.’ (ID 5, age 20–25, born in a Nordic
country)Most of the women were in stable relationships, where they had disclosed their
HIV status and experienced good support from their partners.
Some women, however, had not told their partners about their HIV status, which
caused much anxiety. These women had often had bad experiences disclosing their
HIV status in the past and were afraid of rejection:‘I didn’t tell my partner about my problem, because I truly had a bad
experience, and I . . . I know maybe it is not good but I . . . I was
concerned also. I was sure there was no risk for him, so I didn’t tell
him and I want to keep my secret.’ (ID 23, age 35–40, immigrant)In addition, some of the participants were still trying to determine the
relationship with the expectant father of their child, not knowing if he would
be involved or whether they would be single mothers. This caused much anguish
and concern, but also many thoughts about their ability to become mothers:‘I am just afraid that my children will not have a father. That they will
only have a mother. So I need to be strong for them.’ (ID 4, age 25–30,
immigrant)Other women found support from counselors and patient
organizations for people living with HIV because they felt this was
a place where they could be open, honest, and understood. Several of the
narratives revealed that many of the women wanted to talk to other women living
with HIV but had concerns about disclosure:‘Because I still have that thing that I need to talk about with somebody
who’s going through the same thing as me. In addition, I’ve never talked
to somebody. But I don’t want to talk to somebody who knows me, because
then they will judge me; maybe they will talk about me with my family
and my friends.’ (ID 21, age 35–40, immigrant)
Discussion
This study showed that women living with HIV have a strong desire to have a normal
pregnancy and to be treated as any other pregnant women. However, this normality is
fragile, and being pregnant and living with HIV does come with unique considerations
and concerns that are fundamental to the women’s experiences. Moreover, the
narratives highlight that interactions with healthcare providers and women’s social
support networks influence their pregnancy experience in both positive and negative
ways.
‘Just a normal pregnancy’
Our finding that being pregnant brought a sense of normality to women living with HIV
and the importance of being treated as ‘normal’ is supported by other
studies.[7,8,33-35] The results from several
meta-syntheses indicate that the burden of HIV is often associated with feelings of
loss of normality, while pregnancy is perceived to be a route to being normal,
making the burden of HIV easier to bear.[7,8] Normality in pregnancy is
defined by social and cultural expectations about pregnancy; the context, and
women’s feminine identity
, and a sense of normality seems to have a supportive, strengthening function
for women living with HIV.
Hence, healthcare professionals should, regardless of their level of previous
experience with HIV, focus on the ordinary aspects of pregnancy and not allow the
presence of HIV to overshadow the care provided.Vaginal delivery was associated with a feeling of normality and social expectations
of ‘good mothering’. However, our findings also revealed that vaginal delivery may
be associated with a lack of control and fear of complications and an increased
concern about perinatal transmission risk. Vaginal birth is recommended in
participating countries if the viral load is suppressed and there are no obstetric
contraindications. Thus, comprehensive, repeated assurances from healthcare
providers are important throughout pregnancy to alleviate any fear and anxiety that
women might be experiencing.
Unique considerations and concerns
Pregnancy can be a complex experience for many women and is composed of ambivalent
experiences such as safety/insecurity and happiness/sadness.
For pregnant women living with HIV, ambivalence is accompanied by anxiety,
worry, and guilt due to the unique considerations and concerns related to their HIV.
The fear of perinatal transmission of HIV was highly prevalent in the women’s
narratives, despite them knowing that the risk of transmission of HIV to their
babies has been almost eliminated, especially in high-income settings.[4,16,24,36] Similar results have been
found in other studies.[12,34] Hence, it is important to acknowledge that in many cases, this
fear of transmission is prevalent until it is confirmed that the baby is not
infected and healthcare providers should not neglect or underplay a woman’s anxiety
and concerns, as this may create mistrust and misunderstanding.Our findings also showed concern related to any adverse effects associated with
antiretroviral therapy, in addition to the prophylactic treatment provided to the
baby after birth. This concern was often connected to feelings of guilt. For many
women, antiretroviral therapy was a reminder of their HIV status. In addition, many
of the women were very grateful for having treatment options. This ambivalence,
which has been reported by others,[37,38] seems to be intensified
during pregnancy because protecting and caring for their babies implied caring for
themselves, pregnancy, and HIV infection.[34,37]
Interactions with healthcare
Unlike previous findings, where women living with HIV have been questioned about why
they were pregnant,[10,39] we found that this concern mainly came from the women
themselves. The narratives highlighted that the women were supported in their choice
to become pregnant, both by healthcare providers and their families, and although
some of them had initial concerns about pregnancy because of their HIV, meetings
with healthcare providers made them feel less concerned and more empowered to go
through with the pregnancy. These findings suggest a positive advancement in the
stigma related to becoming pregnant when living with HIV.Our results underscore the need for person-centered care with a focus on the
individual woman’s experience and context. An important element of this is for
healthcare providers to consciously ensure that women living with HIV do not feel
labeled or judged in interactions.
Healthcare providers can have a large impact on a woman’s feeling of
acceptance, and having access to non-judgemental and compassionate care can make a
woman feel a sense of belonging, not only as a woman living with HIV but also as a
pregnant woman.[10,39]Similar to other studies,[9,12,40,41] the narratives underline that many of the women still
experience – and in many cases expect to experience – stigma and ignorance towards
HIV outside of specialized clinics. This was irrespective of the woman’s cultural
background. Women living with HIV, especially pregnant women living with HIV, are
especially susceptible to the harmful effects of discrimination in
healthcare.[41,42] Thus, ongoing educational interventions targeting healthcare
providers working in non-HIV specialties caring for pregnant women are essential to
reduce discrimination against women living with HIV.
Social support
Many of the women included in this study had limited social support and used
distancing as a method to protect themselves against unwanted disclosure. These
findings are similar to those of Greene et al.,
who, in their study on pregnant women living with HIV in Canada, found that
some women started distancing themselves from social support networks early in their
pregnancy, both figuratively and literally. Our findings emphasize that disclosure
of HIV status is closely tied to social support, as women who had not disclosed
their HIV status struggled with receiving help from their family and friends due to
the risk of unintended disclosure. For many of the women, their primary source of
support came from their partner; being in a relationship wherein women can be open
and protected from the negative feelings related to an HIV diagnosis is particularly supportive.
Fear of rejection and being alone kept some women from disclosing their HIV
status to their partners; furthermore, similar to findings from other
studies,[8,43,44] this was an emotional burden, causing distress and creating
restrictive relational boundaries.Women originating from Nordic countries expressed having more support from both
family and friends. This may be related to disclosure, as many of them were more
open about their HIV status. However, it may also be related to immigration status,
as women who were born abroad may experience limited social support due to
immigration and language barriers. Living with HIV adds another layer, especially if
the women have not disclosed their HIV status, which may intensify feelings of isolation.
Isolation may also be salient because of pregnancy due to cultural and social
norms associated with pregnancy, which may be different compared to those in the
women’s home countries.Peer support from others living with HIV has a positive effect on women living with
HIV during pregnancy.[12,46] This was desired by several of the women in this study;
however, the fear of disclosure prohibited them from acting on it. In addition,
several women noted they felt alone with their HIV diagnosis because public opinion
and most HIV support networks target men who have sex with men. Thus, HIV clinics
and patient organizations should be encouraged to use peer-to-peer counseling
without compromising disclosure as an additional supportive action offered to women
living with HIV.
Strengths and limitations
To our knowledge, these results are the first to capture pregnancy experiences among
women living with HIV in Nordic countries, where free access to healthcare should
ensure appropriate medical treatment and support throughout pregnancy. Moreover, the
interviews were conducted in a time period when the U equals U message (i.e.
undetectable = not transmittable) has become known to women and more people in the society
; this may have impacted the finding that women felt more supported. A key
limitation is that the study only reflects those who were willing to take part in
the overall mixed-methods study,
raising the possibility that there could be some important differences
between those who agreed to take part and those who chose not to do so. Country of
residence and country of birth varied between the women, which could have influenced
the generalizability of the results. Furthermore, the interviews were conducted in
English or Danish only, thus excluding women who speak other languages. However, the
participants were sampled consecutively and had diverse backgrounds and experiences,
thus representing the broad characteristics of women living with HIV in Nordic
countries. The interviews were carried out by one author, thereby increasing
consistency throughout the data collection phase. Ten of the interviews were held by
video conference due to the COVID-19 epidemic, and although an effort was made to
ensure in-depth follow-up questions and probes, non-verbal communication may have
been restricted. The women were encouraged to tell their stories; however, due to
the general mixed-methods project, specific follow-up questions were asked if the
women had not talked about these aspects in the initial part of the interview. This
may have limited the elaboration of the women’s narratives. Nevertheless, many of
the predefined themes were brought up by the women themselves, and follow-up
questions were often used to confirm or refute the relevance of those themes in the
overall mixed-methods project. Several authors participated in the analysis, and
quotations from the interviews were added to further establish credibility. The
different analysis procedures were transparent, thereby increasing replicability and
validity.
Conclusion
In sum, the findings emphasize a feeling of normality in pregnancy among women living
with HIV. However, pregnancy does come with unique considerations and concerns, such
as fear of transmission, the use of antiretroviral therapy in pregnancy, and the
need for specialized care, which highly influence the pregnancy experience.
Healthcare providers should focus on person-centered care, ensuring continuity and
emotional support as well as ensuring that women living with HIV do not feel
discriminated against throughout their pregnancies.Click here for additional data file.Supplemental material, sj-docx-1-whe-10.1177_17455065211068688 for The experience
of pregnancy among women living with HIV in Nordic countries: A qualitative
narrative enquiry by Ellen Moseholm, Inka Aho, Åsa Mellgren, Isik S Johansen,
Merete Storgaard, Gitte Pedersen, Ditte Scofield, Terese L Katzenstein and Nina
Weis in Women’s HealthClick here for additional data file.Supplemental material, sj-docx-2-whe-10.1177_17455065211068688 for The experience
of pregnancy among women living with HIV in Nordic countries: A qualitative
narrative enquiry by Ellen Moseholm, Inka Aho, Åsa Mellgren, Isik S Johansen,
Merete Storgaard, Gitte Pedersen, Ditte Scofield, Terese L Katzenstein and Nina
Weis in Women’s Health
Authors: Jaran Eriksen; Jan Albert; Maria Axelsson; Torsten Berglund; Johanna Brännström; Hans Gaines; Magnus Gisslén; Peter Gröön; Per Hagstam; Lars Navér; Karin Pettersson; Jenny Stenkvist; Anders Sönnerborg; Anders Tegnell Journal: Infect Dis (Lond) Date: 2020-10-12
Authors: M Ørbaek; K Thorsteinsson; M Helleberg; E Moseholm; T L Katzenstein; M Storgaard; I S Johansen; G Pedersen; N Weis; A-M Lebech Journal: HIV Med Date: 2017-05-24 Impact factor: 3.180
Authors: Claire L Townsend; Laura Byrne; Mario Cortina-Borja; Claire Thorne; Annemiek de Ruiter; Hermione Lyall; Graham P Taylor; Catherine S Peckham; Pat A Tookey Journal: AIDS Date: 2014-04-24 Impact factor: 4.177
Authors: Crystal Chapman Lambert; Will L Tarver; Pamela L Musoke; Kristi L Stringer; Samantha Whitfield; Bulent Turan; Riddhi Modi; Michael J Mugavero; Rob J Fredericksen; Sheri Weiser; Mallory O Johnson; Janet M Turan Journal: J Assoc Nurses AIDS Care Date: 2020 Mar-Apr Impact factor: 1.354
Authors: Ellen Moseholm; Micheal D Fetters; Inka Aho; Åsa Mellgren; Isik S Johansen; Merete Storgaard; Gitte Pedersen; Terese L Katzenstein; Nina Weis Journal: BMJ Open Date: 2019-10-15 Impact factor: 2.692
Authors: Ariadna Huertas-Zurriaga; Patrick A Palmieri; Joan E Edwards; Sandra K Cesario; Sergio Alonso-Fernandez; Lidia Pardell-Dominguez; Karen A Dominguez-Cancino; Juan M Leyva-Moral Journal: Reprod Health Date: 2021-07-10 Impact factor: 3.223